Temple University’s Lewis Katz School of Medicine recently published the results of a study that risk stratifies COVID-19 patients—identifying those individuals most at risk of experiencing life-threatening reactions such as the cytokine storm. The Philadelphia-based...
Care
Category
European Pharma Consortium Secures €77.7m to Develop COVID-19 Therapeutics Over Next 5 Years
A new consortium was formed in Europe supported by the Innovative Medicines Initiative (IMI) public-private partnership called CARE (Corona Accelerated R&D in Europe). Infused with €77.7 million, CARE is funded by cash contributions from European Union (EU) and...
New York’s First Proton Therapy Center Completed
The $300 million Stantec-designed facility will offer advanced cancer care to 1,400 patients annually. The New York Proton Therapy Center, the first facility of its kind in the state, reached a significant milestone on June 6, with project partners celebrating the...